WHAT'S KNOWN ON THIS SUBJECT: Approximately 1.1% to 5.9% of febrile infants aged ,90 days have bacteremia, but the incidence of bacteremia in this age is unknown. Escherichia coli, group B Streptococcus, and Staphylococcus aureus are the leading causes of bacteremia.
Changing Epidemiology of Bacteremia in Infants Aged 1 Week to 3 Months
WHAT'S KNOWN ON THIS SUBJECT: Approximately 1.1% to 5.9% of febrile infants aged ,90 days have bacteremia, but the incidence of bacteremia in this age is unknown. Escherichia coli, group B Streptococcus, and Staphylococcus aureus are the leading causes of bacteremia.
WHAT THIS STUDY ADDS: Bacteremia occurs in 2.2% of infants who have a blood culture drawn. The incidence rate of true bacteremia was 0.57 in 1000 full-term births. The most common pathogens were Escherichia coli (56%), group B Streptococcus (21%), and Staphylococcus aureus (8%).
abstract BACKGROUND: Bacteremia in young infants has remained an important ongoing concern for decades. Despite changes in prenatal screening and infant immunizations, the current epidemiology of this problem has received little attention.
METHODS:
We conducted a retrospective analysis of all blood cultures collected at Kaiser Permanente Northern California on full-term, previously healthy infants presenting for care between 1 week to 3 months of age for whom a blood culture was drawn from January 1, 2005, through December 31, 2009.
RESULTS:
During the study period, 4255 blood cultures were collected from 160 818 full-term infants. Only 2% of all blood cultures were positive for pathogens (93/4255), whereas 247 positive cultures were due to contaminants. The incidence rate of true bacteremia was 0.57 in 1000 full-term births. The most common pathogen was Escherichia coli (56%). Ninety-eight percent of infants with E coli bacteremia had a urinary tract infection. Group B Streptococcus and Staphylococcus aureus were the second and third most common pathogens, respectively. There were no cases of Listeria monocytogenes bacteremia or meningococcemia and only 1 case of enterococcal bacteremia. Ampicillin resistant pathogens accounted for 36% of organisms.
CONCLUSIONS:
Our study indicates bacteremia in young infants occurs infrequently and in only 2.2% of those who had a blood culture drawn. On the basis of the epidemiology of pathogens found in this large cohort, these data suggest a change in currently recommended presumptive antibiotic coverage in 1-week to 3-month-old infants with suspected bacteremia. Pediatrics 2012;129:e590-e596 Bacteremia in young infants, although uncommon, has been a challenging problem for decades because potentially serious consequences in this age group. Most studies have focused on febrile infants, were completed before implementation of changes in prenatal screening for group B Streptococcus (GBS), and are not population based. Although ∼1.1% to 5.9% of febrile infants ,90 days have bacteremia, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] the incidence of bacteremia in this age group is unknown. Surveillance data are available for GBS and Listeria monocytogenes, 12,13 but there are no published incidence data for other pathogens. Existing prospective studies have been designed to report rates of bacteremia in febrile infants. Including only febrile infants may miss cases of bacteremia occurring in hypothermic or euthermic but ill-appearing infants.
Although late-onset bacteremia occurring after 7 days appears to be decreasing, there has been a paucity of bacteremia studies published in the past decade. Studies from the 1980s consistently report higher rates of bacteremia compared with those from the early 2000s, 3.5% to 4% vs ,3%, respectively. [3] [4] [5] [6] 8, [10] [11] [12] 14 Many factors affect the rate, epidemiology, and risk factors of bacteremia, including differences in perinatal care (eg, intrapartum antibiotics), immunization policies with resultant herd immunity, food safety, and emergence of new pathogens.
METHODS
Approval to conduct this study was granted by the Institutional Review Board of Kaiser Permanente Northern California (KPNC). Informed consent was waived.
Study Design
This study was a retrospective review of the computerized medical database containing all blood culture results in full-term infants aged1 weekto3 months 15 Potential cases were defined as infants with positive blood cultures collected in the outpatient setting, emergency department, or first 24 hours of hospitalization. Additional blood cultures obtained within 3 days of a positive or negative blood culture were not considered a unique episode and were not included in the analysis unless they identified a new pathogen. Subjects were previously healthy and full term, defined as $37 weeks at birth. Blood cultures obtained after an episode of clinically significant bacteremia were excluded. Infants with underlying medical conditions were excluded.
To analyze clinically significant bacteremia, all organisms identified in blood cultures were classified as either a likely contaminant or a potential pathogen. Bacterial isolates such as coagulasenegative staphylococci, Micrococcus species, and diphtheroids were considered contaminants.
Fever was defined as a recorded temperature .100.4°F (38.0°C) rectally. Documentation of a temperature $100.4°F by parent before arrival to medical care qualified as a fever. Ill appearance at presentation was a physician' s description as "toxic," "lethargic," "ill appearing," "nonresponsive," or "inconsolable."
To assess concomitant urinary tract infection (UTI) and meningitis, white blood cell (WBC) count, urinalysis, cerebral spinal fluid (CSF) analysis, urine and CSF culture results were assessed if obtained within 2 days of blood culture acquisition in all infants with a clinically significant positive blood culture. Urinalysis results were considered positive if the specimen contained leukocyte esterase and/or had $5 WBCs per high powered field. UTI was defined as a catheterized urine culture with $10 000 colony-forming units of a single organism per milliliter. Bacterial meningitis was defined as a positive CSF culture with or without CSF pleocytosis (WBC .20, infants 1-4 weeks; WBC .6, infants .4 weeks-3 months).
A case-control retrospective review of the medical record identified risk factors (eg, WBC count, pyuria, clinical signs) associated with bacteremia. Cases were defined as infants with clinically significant positive blood cultures. Controls were defined as infants with negative or clinically insignificant blood cultures and were selected from the pool of negative blood cultures. The case and control were matched 1:1 on age of culture acquisition (61 week), time of year of culture acquisition (61 months), and gender. Controls were equal in number to cases and chosen with the closest match to cases as described above.
Statistical Analysis
The overall incidence rate of bacteremia among infants 1 week to 3 months was calculated and reported. (Fig 1) . There was a significantly higher rate of contaminants in cultures obtained from the emergency department (133/247) compared with those obtained elsewhere (P = .002).
Of 4255 blood cultures, 92 (2.2%) were positive with a pathogen (Fig 1) . The incidence rate of true bacteremia was 92 in 160 818 or 0.57 per 1000 full-term births. Eighty-six of 92 infants with bacteremia had documentation of temperature. Six of 86 (7%) had no documented fevers by parental history or during initial medical care including 2 hypothermic infants who expired soon after presentation. Eighty-four infants with bacteremia had clinical descriptions recorded at presentation. Sixteen (18.6%) were described as ill appearing. Of the 10 infants with meningitis, 1 was afebrile with an axillary temperature of 100°F at home. Seven of the 10 were ill appearing at presentation.
Gender, race, ethnicity, and age were not independent risk factors for bacteremia (Table 1) . Bacteremia was more likely to be identified in infants during 7 to 28 days compared with 29 to 60 and 61 to 92 days (2.84%, 1.92%, and 2.14%, respectively), but this difference was not statistically significant. Over the 5 years of the study, there was no statistically significant change in the incidence of bacteremia. There were no cases of L monocytogenes or Neisseria meningitidis bacteremia. Ampicillin-resistant pathogens accounted for 33 of 92 (36%) of the identified pathogens. Only infants with Escherichia coli, GBS, and Streptococcus pneumoniae bacteremia had concomitant meningitis (Table 2) .
Gram-negative organisms accounted for the majority (58/92, 63%) of bacterial pathogens and E coli (52/92, 56%) was the most common overall ( Table 2 ). The incidence rate of E coli bacteremia was 0.32 in 1000 births and was
FIGURE 1
Flow diagram of excluded infants and blood cultures. a Three infants with 4 blood cultures before positive culture are in both negative and positive boxes.
evenly spread throughout the first 3 months of life. Thirty-six (69%) were male. With univariate analysis, male gender was a predictor of E coli bacteremia (P = .05). By using multivariate logistic regression comparing age, gender, and race, no predictor was statistically significant. Gender approached statistical significance (P = .058). Strains were resistant to ampicillin (23/52, 44%), gentamicin (3/52, 5.8%), and cefazolin (1/ 52, 2%). All 3 gentamicin-resistant strains were also ampicillin resistant. There were no ceftriaxone resistant strains of E coli.
Of the 52 infants with E coli bacteremia, 47 had a urinalysis, 48 had a urine culture, and 38 had a CSF culture and analysis. Forty-seven of 48 infants (98%) had a concomitant UTI. In infants with E coli bacteremia, urinalysis with positive leukocyte esterase was a strong predictor of E coli UTI with 42 of 47 (89%) positive. Four of 38 infants had concomitant E coli meningitis. Of the 14 infants without CSF obtained, all received short-course antibiotics without relapse or sequelae. Three of the 4 meningitis cases were pan-sensitive E coli, and 1 case was ampicillin resistant. All 4 cases occurred in male infants aged 23 to 41 days (median: 35.5 days).
GBS was the second most common pathogen (19/92, 21%; Table 2 ). The incidence rate of late-onset GBS bacteremia was 0.11/1000 births. Only 1 case occurred from 2 to 3 months. By using a Cochran-Armitage Trend test compared with no bacteremia, there was a significant trend toward a decreasing incidence with age with the respective rates of positive blood cultures being 8.6 per 1000, 3.4 per 1000, and 1.1 per 1000 (P = .02). Maternal GBS status was known in 18 of 19 at delivery. Eleven of 18 (61%) had positive screening. Of 19 cases of GBS bacteremia, 5 of 17 (29%) had concomitant meningitis, and 2 deaths occurred. Of the infants with meningitis, 2 of 5 were boys, aged from 14 to 82 days (median: 22 days), and 1 case occurred outside the neonatal period (.30 days).
S aureus was the third most common organism (7/92, 8%) with no cases of methicillin-resistant S aureus (Table 2) . Compared with infants without bacteremia, there was no statistically significant difference in age, gender, or race. Five of the 7 infants underwent a full workup to determine a source of S aureus bacteremia including bone scan and echocardiogram. Associated osteomyelitis occurred in 1 case, endocarditis occurred in no cases, and there was 1 death due to overwhelming S aureus sepsis. One case had concomitant influenza A. One infant' s mother had (14) 3 (21) 19 (21) 888 (22) a P value reflects infants with bacteremia to those without. mastitis. The 5 infants with bacteremia without a source received 2 weeks of antibiotics, and all recovered without complications.
There were 3 cases of S pneumoniae bacteremia (Table 2) . Two infants had CSF obtained, and 1 had concomitant meningitis. There were no cases of neonatal S pneumoniae. All cases were penicillin, ampicillin, and ceftriaxone susceptible.
Controls for comparison of peripheral WBC counts were age, gender, and time of year of blood culture acquisition matched with cases. All 92 infants with bacteremia had a concurrent complete blood count obtained, but data on absolute neutrophil count was not available. Cases had an average WBC count of 13.82 K/uL (range: 1.90-42.30, SD: 7.24), whereas matched controls had an average WBC of 10.77 K/uL (range: 2.90-37.30, SD: 5.96; P = .0012). The average WBC of all subjects with E coli was 15.58 K/uL (SD: 7.33), with GBS was 8.26 K/uL (SD: 5.82), with S aureus was 14.17 K/uL (SD: 4.98) and with S pneumoniae was 23.9 K/uL (SD: 3.94). Only E coli had statistically higher WBC than controls.
The number of cases of other pathogens was too small to detect any actual differences.
DISCUSSION
This large case series was unique in analyzing the incidence and epidemiology of bacteremia in healthy full-term infants aged 1 week to 3 months. The incidence rate of late-onset bacteremia was 92 in 160 818 or 0.57 per 1000 fullterm births. E coli, GBS, and S aureus bacteremia occurred in 0.32, 0.11, and 0.04 per 1000 full-term births, respectively. This incidence was stable over the 5 study years. Before this study, the incidence of late-onset bacteremia was unknown. Compared with Centers for Disease Control and Prevention surveillance data, 12 we have documented a lower incidence of GBS bacteremia.
Our study had some limitations. This was a retrospective review of all blood cultures obtained in full-term infants aged 1 week to 3 months old. Despite using International Classification of Diseases, Ninth Revision codes to identify infants with underlying medical problems, some may have been missed. The demographics of KPNC may not represent all of Northern California or the United States. Acquisition of a blood culture was at the clinician' s discretion and was obtained for reasons other than fever. KPNC is an established health maintenance organization with the vast majority of patients receiving all their care from a KPNC facility. If a bacteremic infant was ill, the infant would likely return to a KPNC facility for follow-up. Therefore, most clinically significant bacteremia would eventually be captured. Some bacteremic infants may have been treated with antibiotics without a blood culture, and so an episode of bacteremia may have been missed. Even with these limitations, we feel confident that our study accurately reported incident rates of bacteremia by capturing bacteremic infants presenting to care and analyzing all blood cultures received at the microbiology laboratory.
The rate of bacteremia was 2.2%, which was 0.1% to 0.5% lower than other publications from the past decade [1] [2] [3] [4] [5] 10 but higher than another large study with a rate of 1.1%. 11 Differences in rates are likely due to study design, setting, and population. We included infants who were full term, previously healthy, aged 1 week to 3 months. Other studies included late preterm infants and infants ,1 week old, which increased the likelihood of bacteremia. Although recognizing these may not have been pathogens, we also included viridans group streptococcal and enterococcal bacteremia cases that were treated by clinicians. Blood cultures were obtained at the clinician' s discretion, and 7% of infants with bacteremia did not have documented fever. We assumed a greater proportion of infants without bacteremia also did not have fever. Similar to other publications, we saw no cases of L monocytogenes or N meningitidis bacteremia. 4, 5 In our KPNC study on infants aged 3 months to 3 years, we reported E coli as the leading cause of bacteremia in infants during the first year of life. 16 This pathogen was also the most common cause of bacteremia in younger infants, and we continued to see a strong association with UTI.
Until the past several years, GBS had been considered the most common pathogen in young infants in the United States. 17 Similar to other studies in the past decade, E coli replaced GBS as the leading cause of culture proven lateonset bacteremia. [3] [4] [5] 10 Even though other studies report E coli as the most common cause of late-onset bacteremia, we found a higher percentage of bacteremia attributable to Gramnegative organisms (63%) and E coli (56%) than other studies. 3, 5 The reason our rates of E coli bacteremia were higher than other published rates (56% vs 25%-45%, 3,5,10 respectively) was most likely multifactorial. Other studies have seen a correlation with intrapartum antibiotics and risk for late-onset serious bacterial infections and ampicillin resistant pathogens. 18 We question whether there was increased E coli and Gram-negative bacteremia secondary to excellent maternal screening for GBS and resultant increased use of intrapartum antibiotics.
We were likely reporting more cases of E coli and fewer cases of GBS. The incidence of late onset GBS was 0.11 in 1000 births, which was one-third of Centers for Disease Control surveillance rates last reported for 1996 through 2004. 12 The lower incidence was likely due to many reasons other than years of the study. It was well established that African American race, prematurity, infants not discharged from the hospital after birth, and cultures obtained more than 24 hours of hospitalization were risk factors for GBS. 19 By including only full term previously healthy infants presenting to care, we excluded infants with higher rates of GBS. KPNC has very high rates of maternal GBS screening and use of intrapartum antibiotics which may decrease horizontal transmission of GBS. KPNC also had a considerably lower African American population which may further lower the rates of GBS.
Ampicillin-resistant pathogens accounted for 36% of cases including 1 case of E coli meningitis. There were no cases of L monocytogenes bacteremia and only 1 case of enterococcal bacteremia. This resistance pattern raised the question of whether ampicillin should be included as initial antibiotics in infants with suspected bacteremia. Our study included infants from all of Northern California and may not be generalizable to recommend antibiotic changes for the United States. However, we have identified a discordance between standard empirical coverage and organism susceptibility. We doubt infants in Northern California need ampicillin as part of the empirical regimen. In addition, we find it disconcerting that E coli strains from 3 bacteremic infants were resistant to both gentamicin and ampicillin. At the very least, if Gram-negative meningitis is suspected, therapy should include cefotaxime. Therapy is not adequate to cover the third most frequently identified pathogen, S aureus. We propose that if infants present with signs of skin and soft tissue infection, endocarditis, osteomyelitis, or other concerns for S aureus, therapy is tailored to treat this pathogen. If changes are made to empirical antibiotics, they should include ampicillin-resistant Gram-negatives and S aureus. Additional studies are underway to determine risk factors for ampicillin-resistant pathogens in our patient population.
CONCLUSIONS
This large cohort study has identified a shift in the epidemiology of bacteremia in term infants. Although bacteremia was a rare occurrence in infants, it did occur in 0.57 of 1000 full-term births. GBS bacteremia is no longer the leading cause of bacteremia but occurs most frequently in the first month of life, and 29% had concomitant meningitis. E coli is now the leading cause of bacteremia, and S aureus follows GBS. These 3 organisms are now responsible for 85% of bacteremia cases. There were no cases of L monocytogenes bacteremia and 1 case of enterococcal bacteremia, and 36% of pathogens were ampicillin resistant. On the basis of the pathogens found and antibiotic susceptibilities, we suggest new strategies are for presumptive treatment of bacteremia and question whether ampicillin still needs to be part of every empirical antibiotic regimen in infants 1 week to 3 months old.
